Immunology & Cell Biology

Publishing Critical Research since 1924

2024 Impact Factor 3.0
2024 Scopus Citescore 6.1

ICB spans the breadth of immunology with an emphasis on the cell biology of the immune system. Of particular interest are the areas of cellular immunology, innate and adaptive immunity, immune responses to pathogens, tumour immunology, immunopathology and immunogenetics.

ICB is the home to 90 publications by Burnet in developing his theories leading to the award of the Nobel Prize in Physiology in 1960.

IMMUNOLOGY & CELL BIOLOGY COVERS:

Cellular immunology
Immune responses to pathogens
Immunopathology
Immunogenetics
Innate and adaptive immunity
Tumour immunology
Immunotherapy
Immunological studies in humans and model organs (including mouse, rat, Drosophila, etc.)

FEATURES OF IMMUNOLOGY & CELL BIOLOGY

Quality peer review and a 100-year reputation for excellence
Rapid evaluation for publication
Average time to first decision of 2 days and average time to acceptance 7 days
No publishing fee for subscription articles or for Open Access articles covered under a Transformative Agreement
Option for Expedited Review if your manuscript has recently undergone peer review at an approved journal with average time to acceptance 7 days
2023 Impact Factor 3.2
2023 Scopus CiteScore 7.5
Outstanding Observations – Rapid publication of cutting-edge research
Original Articles, Reviews, Perspectives, News & Commentaries
Special Features
Virtual Issues
Member of COPE for responsible publication ethics
Eligibility for the Immunology and Cell Biology Social Impact Award

ADDITIONAL BENEFITS FOR ASI MEMBERS

Most members covered under the CAUL Transformative Agreement for Open Access publication
For remaining members, receive a 20% discount off the Article Publication Charge for Open Access*
Be in the running for the award of ‘ICB Publication of the Year’, which also includes a speakers slot at the ASI annual meeting**

*Eligible only to current financial ASI members. To receive the member-only code, please contact us. Further information about the Wiley-CAUL agreement can be found here https://authorservices.wiley.com/author-resources/Journal-Authors/open-access/affiliation-policies-payments/institutional-funder-payments.html
**Awarded to the best publication from a current financial ASI member who is first author.

ICB Website

ICB has an Expedited Review process

Immunology & Cell Biology challenges the culture of scientific publishing
Immunology & Cell Biology is committed to making a positive culture change in scientific publishing.
'ICB Expedited Review' is an exciting new initiative. ICB is trialling a new, fast-tracked review process of articles with validated reviews at other reputable journals.

Key Features of 'ICB Expedited Review'
ICB will use external peer reviews to make the first decision.
Authors can transfer reviews from another journal to ICB, together with a point-by-point response.
Click here to learn more.

ICB CLASSIC PAPERS

	The growth of mouse bone marrow cells in vitro. Bradley, T.R. & Metcalf, D. Aust J Exp Biol Med Sci 44, 287-299 (1966). >2000 citations – a cornerstone publication allowing identification and characterisation of CSFs.
	A reassessment of the forbidden clone hypothesis of autoimmune disease. Burnet, F.M. Aust J Exp Biol Med Sci 50, 1-9 (1972). 1 of 90 publications by Burnet in developing his theories leading to the award of the Nobel Prize in Physiology in 1960.